| Observation of the Efficacy of Different Vitrectomy Systems to Treat Proliferative Diabetic Retinopathy (NCT05446948) | Tianjin Medical University Eye Hospital | 2022-07-11 |
| Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR Patients (NCT05642793) | Peking University Third Hospital | 2022-04-01 |
| Anti-VEGF in Real-world (NCT05222633) | Wenbin Wei | 2022-01-01 |
| A Study on the Treatment Strategy of NVG Secondary to PDR (NCT05156021) | Ruijin Hospital | 2021-12-12 |
| Discovering Early Biomarkers in Circulating Endothelial Cells for Diabetes Complications by Single Cell RNA Sequencing (NCT05169502) | Aarhus University Hospital | 2021-12-08 |
| Efficacy and Safety Comparison of IVR and IVC Before Vitrectomy in Proliferative Diabetic Retinopathy (NCT05414149) | Peking University People's Hospital | 2021-09-01 |
| Comparison of Surgery Outcome Between Preoperative IVR and Intraoperative IVR in PPV for PDR (NCT05408416) | Peking University People's Hospital | 2021-09-01 |
| Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy (NCT04674254) | Cairo University | 2021-03-30 |
| Pre-vitrectomy Intravitreal Ranibizumab for Patients With Proliferative Diabetic Retinopathy Combined With Diabetic Macular Edema (NCT04464694) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2020-09-01 |
| Gas Tamponade for Prevention of Postoperative Vitreous Hemorrhage in Diabetics (NCT04380077) | Rush Eye Associates | 2020-05-15 |
| Intravitreal Bevacizumab vs Laser vs Combination of Bevacizumab and Modified Laser in PDR (NCT04800679) | Shahid Beheshti University of Medical Sciences | 2020-03-01 |
| Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy (NCT02911311) | Sun Yat-sen University | 2019-10-12 |
| The Effect of IVA for Preventing Postvitrectomy Hemorrhage in PDR (NCT05478967) | Peking University People's Hospital | 2019-08-08 |
| Anti-VEGF Instead of Intraoperative PRP in Proliferative Diabetic Retinopathy (NCT03633266) | Wenzhou Medical University | 2018-09-01 |
| Retrospective Review of Proliferative Diabetic Retinopathy Patients (NCT03609996) | Elman Retina Group | 2018-06-01 |
| Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy (NCT05514925) | Khairallah Moncef | 2017-11-21 |
| Macular Hole After Diabetic Vitrectomy (NCT03525899) | National Taiwan University Hospital | 2017-11-01 |
| Effectiveness of Multimodal Imaging for the Evaluation of Retinal Oedema And New vesseLs in Diabetic Retinopathy (NCT03490318) | Belfast Health and Social Care Trust | 2017-10-26 |
| Day Regimes of CONbercept on CytokinEs of PDR Patients Undergoing Vitrectomy - Trial (CONCEPT) (NCT03506750) | The First Affiliated Hospital with Nanjing Medical University | 2017-06-03 |
| The Individually-Marked Panretinal Laser phoTocoagulation for Proliferative Diabetic Retinopathy Study (TREAT) (NCT03113006) | Odense University Hospital | 2017-05-01 |
| Anti-VEGF vs. Prompt Vitrectomy for VH From PDR (NCT02858076) | Jaeb Center for Health Research | 2016-11-01 |
| Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy (NCT02863354) | Charles C Wykoff, PhD, MD | 2016-08-01 |
| Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy (NCT02816710) | Ruijin Hospital | 2016-07-01 |
| Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH (NCT02976012) | Southeast Retina Center, Georgia | 2016-06-01 |
| Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy (NCT02753400) | Kubota Vision Inc. | 2016-05-01 |
| PRP vs Bevacizumab for PDR Treatment (NCT02705274) | Marashi Eye Clinic | 2016-02-01 |
| Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioN (NCT02630277) | Valley Retina Institute | 2016-01-01 |
| Analysis of Aqueous and Vitreous Humor (NCT02067013) | California Retina Consultants | 2015-07-01 |
| 25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial (NCT02447185) | JUNYAN ZHANG | 2015-06-01 |
| 25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China (NCT02328118) | JUNYAN ZHANG | 2015-02-01 |
| Nd:YAG Laser Hyaloidotomy for Premacular Hemorrhage in Diabetic Eyes (NCT04285151) | Tanta University | 2015-01-01 |
| Intravitreal Injection of Ranibizumab Versus Sham Before Vitrectomy in Patients With Proliferative Diabetic Retinopathy (NCT02857491) | Sun Yat-sen University | 2014-07-01 |
| Genetic Markers and Proliferative Diabetic Retinopathy (NCT02879422) | CHU de Reims | 2013-10-16 |
| Diabetes PRP and OCT (NCT01928550) | Oregon Health and Science University | 2013-08-01 |
| Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema (NCT02096874) | King Khaled Eye Specialist Hospital | 2013-06-01 |
| Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study (NCT01813773) | Ophthalmic Consultants of Long Island | 2013-03-01 |
| Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography (NCT01790945) | Retina Institute of Hawaii | 2013-02-01 |
| Surgical Outcomes for Proliferative Diabetic Retinopathy by Preoperative Glycemic Control and Renal Function (NCT03522311) | Kyorin University | 2013-01-01 |
| Safety and Efficacy of Low-Fluence PRP for PDR (NCT01737957) | Asociación para Evitar la Ceguera en México | 2012-11-01 |
| Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion (NCT01724554) | Ophthalmic Consultants of Boston | 2012-11-01 |
| Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy (NCT01627977) | Federal University of São Paulo | 2012-10-01 |
| Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy (NCT01921192) | University of Catania | 2012-09-01 |
| Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy (NCT01724385) | Khon Kaen University | 2012-08-01 |
| Gene Expression in Patients With Epiretinal Membranes (NCT01946451) | Medical University of Silesia | 2012-06-01 |
| Retinal Laser by Multi-spot Photocoagulator and Driving Eligibility (NCT01383772) | Moorfields Eye Hospital NHS Foundation Trust | 2012-06-01 |
| Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy (NCT01854593) | Nihon University | 2012-05-01 |
| Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema (NCT01571232) | Retina Macula Institute | 2012-04-01 |
| A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy (NCT01589718) | Greater Houston Retina Research | 2012-04-01 |
| A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP) (NCT01589029) | PD Dr. med. Stephan Michels | 2012-04-01 |
| Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy (NCT01489189) | Jaeb Center for Health Research | 2012-03-01 |
| Changes in Vitreous Temperature During Phacoemulsification (NCT01568242) | Asociación para Evitar la Ceguera en México | 2012-02-01 |
| PASCAL Laser Versus ETDRS Laser Associated With Intravitreal Ranibizumab (IVR) Versus Only IVR for Proliferative Diabetic Retinopathy (NCT02005432) | University of Sao Paulo | 2012-02-01 |
| Propranolol for Diabetic Retinopathy (NCT01535495) | University of Wisconsin, Madison | 2012-02-01 |
| Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy (NCT01478737) | Anders Kvanta | 2011-11-01 |
| Bevacizumab as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy (NCT01389505) | Instituto do Coracao | 2011-02-01 |
| Macular Tractional Retinoschisis in Proliferative Diabetic Retinopathy (NCT01312207) | National Taiwan University Hospital | 2011-02-01 |
| Vitrous Analysis in Proliferative Diabetic Retinopathy (NCT01478763) | Anders Kvanta | 2011-01-01 |
| Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) (NCT00996437) | Jaeb Center for Health Research | 2010-06-01 |
| Trial of Yellow 577 nm Laser Versus Green 532 nm Laser for Proliferative Diabetic Retinopathy (NCT01044875) | University of Malaya | 2009-09-01 |
| Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab (NCT00776763) | Ophthalmological Association Edelweiss | 2008-10-01 |
| Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study) (NCT00993525) | University of Sao Paulo | 2008-09-01 |
| Compliance to Ophthalmic Follow-up Examinations and Surgical Outcome for Proliferative Diabetic Retinopathy (NCT01307072) | Kyorin University | 2008-09-01 |
| Bevacizumab Versus Ranibizumab for Diabetic Retinopathy (NCT00545870) | Ursula Schmidt-Erfurth, M.D. | 2008-06-01 |
| Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy (NCT00745498) | Seoul National University Bundang Hospital | 2008-06-01 |
| Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy. (NCT00802269) | Asociación para Evitar la Ceguera en México | 2008-03-01 |
| Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging (NCT00606138) | Rush University Medical Center | 2008-01-01 |
| Macugen for Proliferative Diabetic Retinopathy Study With Extended Dosing (M-PDRS ED) (NCT01486771) | Valley Retina Institute | 2007-11-01 |
| Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment (NCT00563043) | Asociación para Evitar la Ceguera en México | 2007-10-01 |
| Changes in Macular Thickness After Patterns Scan Laser (NCT00563628) | Asociación para Evitar la Ceguera en México | 2007-10-01 |
| Morphological and Functional Retinal Changes Following Retinal Photocoagulation (NCT00682240) | Medical University of Vienna | 2007-10-01 |
| Comparison of Small-gauge Vitrectomy and Conventional Vitrectomy for Proliferative Diabetic Retinopathy (NCT01758757) | Kyorin University | 2007-09-01 |
| Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy (NCT00516464) | Retina Associates, Kansas City | 2007-08-01 |
| Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery (NCT01069341) | Bhagat, Neelakshi, M.D., M.P.H. | 2007-07-01 |
| Efficacy of PreOperative Bevacizumab for Diabetic Eye Disease (NCT01041690) | Cairo University | 2007-06-01 |
| Intravitreal Bevacizumab Pretreatment for Reducing Preretinal Hemorrhage in Diabetic Vitrectomy (NCT00596505) | National Taiwan University Hospital | 2007-04-01 |
| Efficacy of Higher Cutting Rate in Microincision Vitrectomy for Proliferative Diabetic Retinopathy (NCT02464800) | Kyorin University | 2007-04-01 |
| Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy (NCT00445003) | Jaeb Center for Health Research | 2007-03-01 |
| Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II) (NCT00668785) | Jumper, J. Michael, M.D. | 2007-03-01 |
| Bevacizumab and Long Acting Gas in Diabetic Vitrectomy (NCT00656435) | National Taiwan University Hospital | 2006-12-01 |
| Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema) (NCT00446381) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2006-10-01 |
| Analgesic Effect of Etoricoxib (ARCOXIA®) 120MG During Retinal Laser Photocoagulation (NCT00529594) | University of Sao Paulo | 2006-08-01 |
| Intravitreal Bevacizumab for Retinal Disorders (NCT00403026) | Narayana Nethralaya | 2006-08-01 |
| Intravitreal Bevacizumab for Diabetic Retinopathy (NCT00600262) | Asociación para Evitar la Ceguera en México | 2005-12-01 |
| Macular Appearance After Diabetic Vitrectomy (NCT00737022) | National Taiwan University Hospital | 2005-05-01 |
| Vitreous Levels of Cysteine-rich 61 in Patients With Proliferative Diabetic Retinopathy (NCT01920984) | National Taiwan University Hospital | 2005-01-01 |
| HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population (NCT00600236) | Asociación para Evitar la Ceguera en México | 2004-09-01 |
| Macular Hole in Diabetic Retinopathy (NCT00737074) | National Taiwan University Hospital | 2002-01-01 |
| Fractalkine, a CX3C Chemokine, Act as a Mediator of Ocular Angiogenesis (NCT00728598) | National Taiwan University Hospital | 1998-01-01 |
| Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy (NCT01025934) | University of Campania Luigi Vanvitelli | |